Join the Cymbalta group to help and get support from people like you.
Cymbalta News
Antidepressants Linked To Sudden Cardiac Death
FRIDAY, April 4, 2025 – Antidepressants appear to increase people’s risk of sudden cardiac death, a new study says. People taking the mood meds are more likely to die suddenly from heart problems, a...
Incident Gabapentin Use Not Linked to Increase in Falls Versus Duloxetine
TUESDAY, Jan. 7, 2025 – Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine use, according to a study published online Jan. 7 in...
FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain
Indications include osteoarthritis, chronic lower back pain ROCKVILLE, Md., Nov. 4, 2010--The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic...
FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder
INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ – The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the maintenance treatment of...
FDA Medwatch Alert: Cymbalta (duloxetine hydrochloride) - Oct 17, 2005
[Posted 10/17/2005] Eli Lilly and FDA notified healthcare professionals of revision to the PRECAUTIONS/Hepatotoxicity section of the prescribing information for Cymbalta (duloxetine hydrochloride),...
FDA Medwatch Alert: Cymbalta (duloxetine hydrochloride) - Jul 8, 2005
[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...
FDA Medwatch Alert: Antidepressant Medication Products
[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...
FDA Medwatch Alert: Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) - Serotonin Syndrome
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...
Further information
Related condition support groups
Back Pain, Chronic Pain, Anxiety, Depression, Fibromyalgia, Diabetic Neuropathy, Diabetic Nerve Damage, Generalized Anxiety Disorder, Major Depressive Disorder, Osteoarthritis